Anti‐tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer

Abstract

Esophageal cancer is one of the most prevalent types of cancer globally. With current treatment options, the survival is poor, and there are ongoing efforts to find new and more efficient therapeutic approaches. There are several reports on the anti-tumoral effects of low-molecular-weight heparins (LMWH). We have assessed the possible survival benefits and underlying mechanisms of LMWHs in malignancies with a focus on esophageal cancer. We conclude that the effects of LMWHs on survival of cancer patients is probably due to a combination of direct anti-tumoral, anti-angiogenic, and immunomodulatory effects and indirect effects on the coagulation system.

Therapeutic potential of targeting the Wnt/β‐catenin pathway in the treatment of pancreatic cancer

“…There are ongoing efforts to find more individualized, more targeted, and more effective therapeutic approaches in the treatment of cancer . The therapeutic potential of targeting the Wnt pathway in the treatment of some cancers has been reported previously .…”

A case report of mediastinal cavernous hemangioma

“… 16 , 17 Besides, there are promising new data on the underlying molecular mechanisms of different cancer, which may affect the treatment of these benign tumors with the least side effects. 18 , 19 , 20 , 21 …”

A case report of endometrial adenocarcinoma with leptomeningeal metastases

“… 18 , 19 Besides, there are promising new data on the underlying molecular mechanisms of different cancers that may improve the outcome of patients with LM through introducing new drugs and treatment modalities. 20 , 21 , 22 , 23 , 24 …”